Welcome to Wednesday, May 5th, Mickeys and Minnies...
The House Oversight Committee’s Subcommittee on Economic and Consumer Policy held a hearing Tuesday on reforming America’s "grossly inefficient" organ transplant system.
The hearing ― “The Urgent Need to Reform the Organ Transplantation System to Secure More Organs for Waiting, Ailing, and Dying Patients” ― featured testimony from stakeholders including patients on a waitlist for a transplant, a doctor who is a living donor, and experts on the transplant system.
There are 107,000 Americans on an organ transplant waitlist, 33 of whom pass away each day before a transplant becomes available. Additionally, there are hundreds of thousands of Americans who are undergoing dialysis and would benefit from a transplant but aren’t on a waitlist.
Much of the hearing focused on the role played by the nation’s 57 non-profit Organ Procurement Organizations (OPOs), which are certified and regulated by the Centers for Medicare and Medicaid Services (CMS).
OPOs are granted a monopoly over their designated region and focus on obtaining organs from deceased donors, which account for over 80% of transplants.
Should there be reforms to the U.S. organ transplant system?
|